Sterneck Capital Management LLC Takes $207,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Sterneck Capital Management LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 395 shares of the healthcare conglomerate’s stock, valued at approximately $207,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Waycross Partners LLC grew its holdings in UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after buying an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth approximately $515,000. Full Sail Capital LLC lifted its position in shares of UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares during the last quarter. Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $39,413,000. Finally, Silvercrest Asset Management Group LLC lifted its position in shares of UnitedHealth Group by 47.8% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after acquiring an additional 12,550 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. Barclays cut their price objective on UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating for the company in a research report on Thursday, May 15th. Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. JPMorgan Chase & Co. dropped their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research note on Thursday, May 15th. KeyCorp dropped their price target on shares of UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Finally, Mizuho lowered their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $441.87.

UnitedHealth Group Trading Up 1.0%

Shares of NYSE:UNH opened at $301.08 on Friday. The company has a market cap of $273.12 billion, a P/E ratio of 19.42, a P/E/G ratio of 1.37 and a beta of 0.56. The stock’s 50-day moving average is $430.87 and its 200-day moving average is $493.45. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the business posted $6.91 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In related news, Director John H. Noseworthy bought 300 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the purchase, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company’s stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.